Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Aquestive Therapeutics, Inc. (AQST) had Receiveable Turnover of 5.97 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$50.58M |
|
$-7.87M |
|
$20.83M |
|
$29.75M |
|
$65.69M |
|
$-15.10M |
|
$7.48M |
|
$-7.62M |
|
$-7.62M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-7.87M |
|
$-15.10M |
|
$-11.79M |
|
61.26M |
|
61.26M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$40.97M |
|
$4.18M |
|
$16.45M |
|
$57.42M |
|
$18.31M |
|
$27.51M |
|
$145.60M |
|
$163.91M |
|
$-106.49M |
|
$-107.77M |
|
$-106.49M |
|
68.53M |
|
| Cash Flow Statement Financials | |
$-6.38M |
|
$-0.99M |
|
$3.97M |
|
$27.27M |
|
$23.87M |
|
$-3.40M |
|
$2.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
-0.35 |
|
-0.26 |
|
58.82% |
|
-29.86% |
|
-29.86% |
|
-23.30% |
|
-15.07% |
|
-15.56% |
|
$-7.38M |
|
-- |
|
-- |
|
-- |
|
0.88 |
|
3.08 |
|
|
Receiveable Turnover |
5.97 |
61.13 |
|
7.39% |
|
7.30% |
|
-13.71% |
|
9.96% |
|
$-1.55 |
|
$-0.12 |
|
$-0.10 |
|